{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:30:46Z","timestamp":1765758646537,"version":"build-2065373602"},"reference-count":44,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T00:00:00Z","timestamp":1623283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The Government of Canada through Genome Canada and the Canadian Institutes of Health Research (GPH-129344), the Minist\u00e8re de l\u2019\u00c9conomie, de la Science et de l\u2019Innovation du Qu\u00e9bec through Genome Qu\u00e9bec, and the Qu\u00e9bec Breast Cancer Foundation","award":["GPH-129344"],"award-info":[{"award-number":["GPH-129344"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPM"],"abstract":"<jats:p>Given the expanding knowledge base in cancer genomics, risk-based screening is among the promising avenues to improve breast cancer (BC) prevention and early detection at the population level. Semi-structured interviews were conducted to explore the perceptions of healthcare professionals (HPs) regarding the implementation of such an approach and identify tools that can support HPs. After undertaking an in-depth thematic content analysis of the responses, 11 themes were identified. These were embedded into a logical model to distinguish the potential eligible participants (who?), the main clinical activities (how?) and associated tools (what?), the key factors of acceptability (which?), and the expected effects of the strategy (why?). Overall, it was found that the respondents positively welcomed the implementation of this strategy and agreed on some of the benefits that could accrue to women from tailored risk-based screening. Some important elements, however, deserve clarification. The results also highlight three main conditions that should be met to foster the acceptability of BC risk stratification: respecting the principle of equity, paying special attention to knowledge management, and rethinking human resources to capitalize on the strengths of the current workforce. Because the functioning of BC risk-based screening is not yet well defined, important planning work is required before advancing this organizational innovation, and outstanding issues must be resolved to get HPs on board.<\/jats:p>","DOI":"10.3390\/jpm11060540","type":"journal-article","created":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T13:31:39Z","timestamp":1623331899000},"page":"540","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Toward a Population-Based Breast Cancer Risk Stratification Approach? The Needs and Concerns of Healthcare Providers"],"prefix":"10.3390","volume":"11","author":[{"given":"Jolyane","family":"Blouin-Bougie","sequence":"first","affiliation":[{"name":"Department of Management, Faculty of Business Administration, Laval University, Qu\u00e9bec City, QC G1A 0A6, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nabil","family":"Amara","sequence":"additional","affiliation":[{"name":"Department of Management, Faculty of Business Administration, Laval University, Qu\u00e9bec City, QC G1A 0A6, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6906-3390","authenticated-orcid":false,"given":"Jacques","family":"Simard","sequence":"additional","affiliation":[{"name":"CHU de Qu\u00e9bec-Universit\u00e9 Laval Research Center, Qu\u00e9bec City, QC G1V 2G4, Canada"},{"name":"Department of Molecular Medicine, Faculty of Medicine, Laval University, Qu\u00e9bec City, QC G1A 0A6, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,6,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1056\/NEJMsr1501341","article-title":"Gene-panel sequencing and the prediction of breast-cancer risk","volume":"372","author":"Easton","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ajhg.2018.11.002","article-title":"Polygenic risk scores for prediction of breast cancer and breast cancer subtypes","volume":"104","author":"Mavaddat","year":"2019","journal-title":"Am. J. Hum. Genet."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/14636778.2018.1549477","article-title":"Organizational challenges to equity in the delivery of services within a new personalized risk-based approach to breast cancer screening","volume":"38","author":"Hagan","year":"2019","journal-title":"New Genet. Soc."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1177\/0894318405284129","article-title":"Innovation in Healthcare: A Systematic Review of Recent Research","volume":"19","author":"Aalto","year":"2006","journal-title":"Nurs. Sci. Q"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41523-017-0035-5","article-title":"The WISDOM Study: Breaking the deadlock in the breast cancer screening debate","volume":"3","author":"Esserman","year":"2017","journal-title":"NPJ Breast Cancer"},{"key":"ref_6","unstructured":"Moorthie, S., Burton, H., and Babb de Villiers, C. (2020). Personalising breast cancer prevention: Bridging the gap between research and policy. PHG Foundation, University of Cambridge."},{"key":"ref_7","first-page":"1","article-title":"Personalized early detection and prevention of breast cancer: ENVISION consensus statement","volume":"17","author":"Pashayan","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-020-07054-2","article-title":"What are the benefits and harms of risk stratified screening as part of the NHS breast screening Programme? Study protocol for a multi-site non-randomised comparison of BC-predict versus usual screening (NCT04359420)","volume":"20","author":"French","year":"2020","journal-title":"BMC Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13058-015-0595-y","article-title":"Can the breast screening appointment be used to provide risk assessment and prevention advice?","volume":"17","author":"Evans","year":"2015","journal-title":"Breast Cancer Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1001\/jamaoncol.2018.1901","article-title":"Cost-effectiveness and benefit-to-harm ratio of risk-stratified screening for breast cancer: A life-table model","volume":"4","author":"Pashayan","year":"2018","journal-title":"JAMA Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.jval.2017.04.012","article-title":"Evaluation of a stratified national breast screening program in the United Kingdom: An early model-based cost-effectiveness analysis","volume":"20","author":"Gray","year":"2017","journal-title":"Value Health"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1365-2796.2012.02525.x","article-title":"Prevention of breast cancer in the context of a national breast screening programme","volume":"271","author":"Howell","year":"2012","journal-title":"J. Intern. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/S0140-6736(15)60123-4","article-title":"Use of a decision aid including information on overdetection to support informed choice about breast cancer screening: A randomised controlled trial","volume":"385","author":"Hersch","year":"2015","journal-title":"Lancet"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10689-020-00188-z","article-title":"Improving primary care identification of familial breast cancer risk using proactive invitation and decision support","volume":"20","author":"Qureshi","year":"2021","journal-title":"Fam. Cancer"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-17680-w","article-title":"European polygenic risk score for prediction of breast cancer shows similar performance in Asian women","volume":"11","author":"Ho","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/s41588-020-0609-2","article-title":"Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses","volume":"52","author":"Zhang","year":"2020","journal-title":"Nat. Genet."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1038\/s41436-018-0406-9","article-title":"BOADICEA: A comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors","volume":"21","author":"Lee","year":"2019","journal-title":"Genet. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1200\/EDBK_158817","article-title":"Refining breast cancer risk stratification: Additional genes, additional information","volume":"36","author":"Kurian","year":"2016","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"250","DOI":"10.2214\/AJR.18.20345","article-title":"Risk stratification for screening mammography: Benefits and harms","volume":"212","author":"Lee","year":"2019","journal-title":"Am. J. Roentgenol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.breast.2018.02.029","article-title":"Are we ready for the challenge of implementing risk-based breast cancer screening and primary prevention?","volume":"39","author":"Rainey","year":"2018","journal-title":"Breast"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2217\/pme-2016-0064","article-title":"Strategies for integrating personalized medicine into healthcare practice","volume":"14","author":"Pritchard","year":"2017","journal-title":"Per. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3390\/jpm5020191","article-title":"Do health professionals need additional competencies for stratified cancer prevention based on genetic risk profiling?","volume":"5","author":"Chowdhury","year":"2015","journal-title":"J. Pers. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40985-019-0111-5","article-title":"Health professionals\u2019 perspectives on breast cancer risk stratification: Understanding evaluation of risk versus screening for disease","volume":"40","author":"Puzhko","year":"2019","journal-title":"Public Health Rev."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/nrclinonc.2018.30","article-title":"Epigenome-based cancer risk prediction: Rationale, opportunities and challenges","volume":"15","author":"Widschwendter","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-020-07158-9","article-title":"Risk stratified breast cancer screening: UK healthcare policy decision-making stakeholders\u2019 views on a low-risk breast screening pathway","volume":"20","author":"McWilliams","year":"2020","journal-title":"BMC Cancer"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/1525822X05279903","article-title":"How many interviews are enough? An experiment with data saturation and variability","volume":"18","author":"Guest","year":"2006","journal-title":"Field Methods"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10689-015-9835-7","article-title":"The knowledge value-chain of genetic counseling for breast cancer: An empirical assessment of prediction and communication processes","volume":"15","author":"Amara","year":"2016","journal-title":"Fam. Cancer"},{"key":"ref_28","unstructured":"Miles, M., Hubberman, A., and Saldana, J. (2014). Qualitative Data Analysis\u2014A Methods Sourcesbook, SAGE. [3rd ed.]."},{"key":"ref_29","unstructured":"QSR International Pty Ltd. (2015). NVivo Version 11, QSR International. Released 2015."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3917\/spub.163.0353","article-title":"Influence des facteurs organisationnels sur l\u2019implantation d\u2019une approche personnalis\u00e9e de d\u00e9pistage du cancer du sein","volume":"28","author":"Hagan","year":"2016","journal-title":"Sante Publique"},{"key":"ref_31","unstructured":"Gouvernement du Qu\u00e9bec (1999). Programme Qu\u00e9b\u00e9cois de D\u00e9pistage du Cancer du Sein\u2014Cadre de R\u00e9f\u00e9rence."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/nrclinonc.2016.50","article-title":"Population-based screening for cancer: Hope and hype","volume":"13","author":"Shieh","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nrclinonc.2016.101","article-title":"A risk-based framework to decide who benefits from screening","volume":"13","author":"Castle","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/GIM.0b013e3181b9b04a","article-title":"Evaluation of a breast\/ovarian cancer genetics referral screening tool in a mammography population","volume":"11","author":"Bellcross","year":"2009","journal-title":"Genet. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3390\/jpm11060511","article-title":"Personalized Risk Assessment for Prevention and Early Detection of Breast Cancer: Integration and Implementation (PERSPECTIVE I&I)","volume":"11","author":"Brooks","year":"2021","journal-title":"J. Pers. Med."},{"key":"ref_36","first-page":"169","article-title":"Primary-care providers\u2019 perceived barriers to integration of genetics services: A systematic review of the literature","volume":"17","author":"Larson","year":"2014","journal-title":"Genet. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/cge.12233","article-title":"Health care provider recommendations for reducing cancer risks among women with a BRCA1 or BRCA2 mutation","volume":"85","author":"Metcalfe","year":"2014","journal-title":"Clin. Genet."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1002\/cncr.28771","article-title":"Breast cancer screening in an era of personalized regimens: A conceptual model and National Cancer Institute initiative for risk-based and preference-based approaches at a population level","volume":"120","author":"Onega","year":"2014","journal-title":"Cancer"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1159\/000362358","article-title":"Medical Genetic Counseling for Breast Cancer in Primary Care: A synthesis of evidence on predictors of clinical practices","volume":"17","author":"Jbilou","year":"2014","journal-title":"Public Health Genom."},{"key":"ref_40","first-page":"143","article-title":"Knowledge management strategy building: Literature review","volume":"8","author":"Shannak","year":"2012","journal-title":"Eur. Sci. J."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/amiajnl-2012-000892","article-title":"Clinical decision support for genetically guided personalized medicine: A systematic review","volume":"20","author":"Welch","year":"2013","journal-title":"J. Am. Med. Inform. Assoc."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40985-018-0083-x","article-title":"Personalized cancer screening: Helping primary care rise to the challenge","volume":"39","author":"Selby","year":"2018","journal-title":"Public Health Rev."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrclinonc.2015.173","article-title":"Population genetic testing for cancer susceptibility: Founder mutations to genomes","volume":"13","author":"Foulkes","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1188\/14.ONF.89-91","article-title":"Methods and meanings: Credibility and trustworthiness of qualitative research","volume":"41","author":"Cope","year":"2014","journal-title":"Oncol. Nurs. Forum."}],"container-title":["Journal of Personalized Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4426\/11\/6\/540\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:12:49Z","timestamp":1760163169000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4426\/11\/6\/540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,10]]},"references-count":44,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["jpm11060540"],"URL":"https:\/\/doi.org\/10.3390\/jpm11060540","relation":{},"ISSN":["2075-4426"],"issn-type":[{"type":"electronic","value":"2075-4426"}],"subject":[],"published":{"date-parts":[[2021,6,10]]}}}